
Chari A, Larson S, Holkova B, et al. Phase 1 trial of ibrutinib
Advertisement
Articles by Chari A, Larson S, Holkova B, et al. Phase 1 trial of ibrutinib

Advertisement
Latest Updated Articles
Study Summary: Ibrutinib Plus Carfilzomib for Relapsed or Relapsed/Refractory Multiple MyelomaPublished: October 18th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Hereditary Ovarian Cancer Genes Found Beyond Traditionally High-Risk Groups
2
ACIP Delayed Hepatitis B Vaccine Schedule Vote Amid Safety Controversy
3
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
4
Medicaid Expansion Associated With Lower Mortality in NSCLC
5



